Bender Robert & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
VCM
VPM
Bender Robert & Associates's MRK Position: Q1 2026 in Review
Bender Robert & Associates reduced its Merck (MRK) stake by 8.1% in Q1 2026, selling an estimated $41.6K and leaving 4,077 shares worth $490K. The position accounts for 0.12% of the portfolio, ranked #33.
Bender Robert & Associates first reported a position in MRK in Q2 2013 and has held it in 51 quarters since. The position peaked at $953K in Q4 2022. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Bender Robert & Associates held 4,077 shares of Merck worth $490K as of Q1 2026.
- Bender Robert & Associates sold 360 Merck shares in Q1 2026, an estimated $41.6K.
- Merck made up 0.12% of Bender Robert & Associates's portfolio in Q1 2026, its #33 holding.
- Bender Robert & Associates first reported a position in Merck in Q2 2013 and has held it in 51 quarters since.
- Bender Robert & Associates's Merck position peaked at $953K in Q4 2022.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Bender Robert & Associates's 13F filing for Q1 2026, filed 23 Apr 2026.